This inventor holds 1 USPTO granted patent. Top assignee: Sclavo Spa. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Giovanni Raugei: Innovator in Yeast Biotechnology
Introduction
Giovanni Raugei is a notable inventor based in Florence, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of expression and secretion vectors in yeasts. His work has implications for the production of heterologous proteins, which are essential in various therapeutic and diagnostic applications.
Latest Patents
Raugei holds a patent for an "Expression and secretion vector in yeasts, useful for preparing heterologous proteins." This invention provides a synthetic oligonucleotide that directs the secretion of heterologous proteins. The oligonucleotide is strategically positioned between an inducible hybrid promoter and a multiple-site polylinker, followed by transcription termination signals recognized by yeast RNA polymerase. The patent also describes a hybrid plasmid created by cloning the DNA sequence coding for a heterologous protein into the vector's polylinker. The process involves cultivating a yeast transformed with the hybrid plasmid in a suitable culture medium and recovering the resulting heterologous proteins, which can include hormones, lymphokines, viral antigens, or immunogens.
Career Highlights
Giovanni Raugei is associated with Sclavo Spa, where he continues to advance his research in yeast biotechnology. His innovative work has positioned him as a key figure in the field, contributing to the development of new methods for protein production.
Collaborations
Raugei has collaborated with notable colleagues such as Cesira Galeotti and Emanuela Palla. Their combined expertise has further enhanced the research and development efforts at Sclavo Spa.
Conclusion
Giovanni Raugei's contributions to yeast biotechnology through his innovative patent have significant implications for the production of essential proteins in the therapeutic and diagnostic fields. His work exemplifies the impact of innovation in advancing biotechnological applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile